MyAverix Finance
NS · Healthcare
Accretion Pharmaceuticals Ltd (ACCPL)
Pharmaceuticals & Biotechnology
Accretion Pharmaceuticals Ltd (ACCPL) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.62B, P/E ratio is 13.57. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ACCPL
Accretion Pharmaceuticals Ltd (ACCPL) — FAQ
What is Accretion Pharmaceuticals Ltd's market cap?
Accretion Pharmaceuticals Ltd (ACCPL) has a reported market cap of $1.62B (data as of 2026-07-10).
What is ACCPL's P/E ratio?
The price-to-earnings (P/E) ratio for Accretion Pharmaceuticals Ltd (ACCPL) is 13.57 (data as of 2026-07-10).
Does Accretion Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Accretion Pharmaceuticals Ltd (ACCPL). Check the MyAverix Finance app for the latest dividend data.
What sector is Accretion Pharmaceuticals Ltd in?
Accretion Pharmaceuticals Ltd (ACCPL) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is ACCPL listed on?
ACCPL is listed on NS.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.